Precision medicine for Parkinson's Disease is focus of new Yale center
Led by Yale researcher Clemens Scherzer, the center will leverage genomics and artificial intelligence to develop tailored therapeutics for the disease.
Led by Yale researcher Clemens Scherzer, the center will leverage genomics and artificial intelligence to develop tailored therapeutics for the disease.